Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.

Minematsu K, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

Cerebrovasc Dis. 2019;48(1-2):53-60. doi: 10.1159/000502883. Epub 2019 Oct 2.

PMID:
31578012
2.

Testicular rhabdomyosarcoma after chemotherapy for metastatic germ cell tumors.

Nakagawa R, Aoyama S, Urata S, Ofude M, Miyagi T, Nakashima T, Okayama Y, Katayanagi K.

Int Cancer Conf J. 2019 Jun 15;8(4):175-180. doi: 10.1007/s13691-019-00378-2. eCollection 2019 Oct.

PMID:
31559118
3.

Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation.

Kitazono T, Ikeda T, Ogawa S, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Cavaliere M, Hayashi Y, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

Heart Vessels. 2019 Sep 6. doi: 10.1007/s00380-019-01487-x. [Epub ahead of print]

PMID:
31492970
4.

Preface to the proceedings of the 32nd Workshop on Eosinophils in Allergy and Related Diseases 2018.

Okayama Y.

Allergol Int. 2019 Sep;68S:S1-S2. doi: 10.1016/j.alit.2019.07.003. No abstract available.

5.

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings.

Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Iwashiro S, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

J Thromb Thrombolysis. 2019 Nov;48(4):653-660. doi: 10.1007/s11239-019-01934-6.

6.

Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function.

Nakagawara J, Ikeda T, Ogawa S, Kitazono T, Minematsu K, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

J Cardiol. 2019 Dec;74(6):501-506. doi: 10.1016/j.jjcc.2019.06.003. Epub 2019 Jul 29.

PMID:
31371191
7.

Mast cells play role in wound healing through the ZnT2/GPR39/IL-6 axis.

Nishida K, Hasegawa A, Yamasaki S, Uchida R, Ohashi W, Kurashima Y, Kunisawa J, Kimura S, Iwanaga T, Watarai H, Hase K, Ogura H, Nakayama M, Kashiwakura JI, Okayama Y, Kubo M, Ohara O, Kiyono H, Koseki H, Murakami M, Hirano T.

Sci Rep. 2019 Jul 25;9(1):10842. doi: 10.1038/s41598-019-47132-5.

8.

Impact of airflow obstruction on long-term mortality in patients with asthma in Japan.

Okayama Y, Kawayama T, Kinoshita T, Tokunaga Y, Sasaki J, Sakazaki Y, Imaoka H, Hoshino T.

Allergol Int. 2019 Oct;68(4):462-469. doi: 10.1016/j.alit.2019.04.009. Epub 2019 May 31.

9.

Autonomous regulation of IgE-mediated mast cell degranulation and immediate hypersensitivity reaction by an inhibitory receptor CD300a.

Wang Y, Nakahashi-Oda C, Okayama Y, Shibuya A.

J Allergy Clin Immunol. 2019 Jul;144(1):323-327.e7. doi: 10.1016/j.jaci.2019.03.005. Epub 2019 May 30. No abstract available.

10.

Importance of Managing the Water-Electrolyte Balance by Delivering the Optimal Minimum Amount of Water and Sodium After Subarachnoid Hemorrhage.

Shikata E, Tamura T, Shinno K, Okayama Y, Shinohara N, Shimada K, Kanematsu Y, Kitazato KT, Nagahiro S, Takagi Y.

World Neurosurg. 2019 Sep;129:e352-e360. doi: 10.1016/j.wneu.2019.05.152. Epub 2019 May 25.

PMID:
31132492
11.

Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.

Izaki S, Toyoshima S, Endo T, Kanegae K, Nunomura S, Kashiwakura JI, Sasaki-Sakamoto T, Nakamura R, Akiyama H, Ra C, Hayama K, Terui T, Okayama Y.

Allergol Int. 2019 Jul;68(3):342-351. doi: 10.1016/j.alit.2019.01.003. Epub 2019 Feb 22.

12.

Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Takeichi M, Ohashi Y, Okayama Y, Sunaya T, Yamanaka S.

J Cardiol. 2019 Jul;74(1):60-66. doi: 10.1016/j.jjcc.2019.01.001. Epub 2019 Feb 8.

PMID:
30745002
13.

CGRP Induces Differential Regulation of Cytokines from Satellite Glial Cells in Trigeminal Ganglia and Orofacial Nociception.

Afroz S, Arakaki R, Iwasa T, Oshima M, Hosoki M, Inoue M, Baba O, Okayama Y, Matsuka Y.

Int J Mol Sci. 2019 Feb 7;20(3). pii: E711. doi: 10.3390/ijms20030711.

14.

A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis.

Ito R, Maruoka S, Soda K, Katano I, Kawai K, Yagoto M, Hanazawa A, Takahashi T, Ogura T, Goto M, Takahashi R, Toyoshima S, Okayama Y, Izuhara K, Gon Y, Hashimoto S, Ito M, Nunomura S.

JCI Insight. 2018 Nov 2;3(21). pii: 121580. doi: 10.1172/jci.insight.121580.

15.

Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria.

Endo T, Toyoshima S, Kanegae K, Izaki S, Nishimori N, Ito M, Sugai K, Hayama K, Terui T, Okayama Y.

Allergol Int. 2019 Apr;68(2):270-273. doi: 10.1016/j.alit.2018.09.006. Epub 2018 Oct 22. No abstract available.

16.

Lipohyperplasia of the ileocaecal valve.

Okayama Y, Kadoya Y, Kenzaka T.

Oxf Med Case Reports. 2018 Aug 11;2018(8):omy047. doi: 10.1093/omcr/omy047. eCollection 2018 Aug.

17.

Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study.

Koretsune Y, Kumagai K, Uchiyama S, Yamashita T, Yasaka M, Watanabe-Fujinuma E, Banderas BF, Akiyama S, Okayama Y, Briere JB, Dickie G, Cano SJ.

Curr Med Res Opin. 2018 Dec;34(12):2157-2164. doi: 10.1080/03007995.2018.1507315. Epub 2018 Aug 14.

PMID:
30067119
18.

Characterization of human decidual mast cells and establishment of a culture system.

Matsuno T, Toyoshima S, Sakamoto-Sasaki T, Kashiwakura JI, Matsuda A, Watanabe Y, Azuma H, Kawana K, Yamamoto T, Okayama Y.

Allergol Int. 2018 Sep;67S:S18-S24. doi: 10.1016/j.alit.2018.05.001. Epub 2018 May 18.

19.

[ACTIVATION MECHANISMS OF MAST CELLS IN CHRONIC SPONTANEOUS URTICARIA].

Okayama Y.

Arerugi. 2018;67(3):192-196. doi: 10.15036/arerugi.67.192. Japanese. No abstract available.

PMID:
29769469
20.

Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.

Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.

Pancreatology. 2018 Apr 30. pii: S1424-3903(18)30079-6. doi: 10.1016/j.pan.2018.04.012. [Epub ahead of print]

PMID:
29730245
21.

Sociodemographic and physical predictors of non-participation in community based physical checkup among older neighbors: a case-control study from the Kyoto-Kameoka longitudinal study, Japan.

Yamaguchi M, Yoshida T, Yamada Y, Watanabe Y, Nanri H, Yokoyama K, Date H, Miyake M, Itoi A, Yamagata E, Masumoto T, Okayama Y, Yoshinaka Y, Kimura M; Kyoto-Kameoka study group.

BMC Public Health. 2018 May 2;18(1):568. doi: 10.1186/s12889-018-5426-5.

22.

Prevalence of Posterior Disc Displacement of the Temporomandibular Joint in Patients with Temporomandibular Disorders: Systematic Review and Meta-Analyses.

Afroz S, Naritani M, Hosoki H, Takechi K, Okayama Y, Matsuka Y.

J Oral Facial Pain Headache. Summer 2018;32(3):277–286. doi: 10.11607/ofph.1924. Epub 2018 Apr 25. Review.

PMID:
29697716
23.

Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Ogawa S, Minematsu K, Ikeda T, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Ohashi Y, Takeichi M, Okayama Y, Yamanaka S, Inuyama L.

J Arrhythm. 2018 Feb 7;34(2):167-175. doi: 10.1002/joa3.12034. eCollection 2018 Apr.

24.

Treatment of Unruptured Cerebral Aneurysms with the Mineralocorticoid Receptor Blocker Eplerenone-Pilot Study.

Nagahiro S, Tada Y, Satomi J, Kinouchi T, Kuwayama K, Yagi K, Nakajima K, Matsushita N, Miyamoto T, Yamaguchi T, Shimada K, Korai M, Mure H, Okayama Y, Abe T, Harada M, Kitazato KT, Kanematsu Y.

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2134-2140. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.008. Epub 2018 Apr 2.

25.

Chirality recognition of winding vine-shaped heterobiaryls with molecular asymmetry. Kinetic and dynamic kinetic resolution by Shi's asymmetric epoxidation.

Maruhashi K, Okayama Y, Inoue R, Ashida S, Toyomori Y, Okano K, Mori A.

Sci Rep. 2018 Jan 26;8(1):1704. doi: 10.1038/s41598-018-19878-x.

26.

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer.

Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T.

Onco Targets Ther. 2017 Oct 24;10:5107-5113. doi: 10.2147/OTT.S145613. eCollection 2017.

27.

Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation.

Shimanaka Y, Kono N, Taketomi Y, Arita M, Okayama Y, Tanaka Y, Nishito Y, Mochizuki T, Kusuhara H, Adibekian A, Cravatt BF, Murakami M, Arai H.

Nat Med. 2017 Nov;23(11):1287-1297. doi: 10.1038/nm.4417. Epub 2017 Oct 9.

PMID:
29035365
28.

In Utero Exposure to Di( n-butyl)phthalate Induces Morphological and Biochemical Changes in Rats Postpuberty.

Okayama Y, Wakui S, Wempe MF, Sugiyama M, Motohashi M, Mutou T, Takahashi H, Kume E, Ikegami H.

Toxicol Pathol. 2017 Jun;45(4):526-535. doi: 10.1177/0192623317709091.

PMID:
28641505
29.

Disulfide-linked dimerization of the FcRγ chain is required for positive and negative regulation of mast cell activation via FcεRI.

Nunomura S, Ra C, Terui T, Okayama Y.

Allergol Int. 2017 Sep;66S:S41-S43. doi: 10.1016/j.alit.2017.04.010. Epub 2017 Jun 17. No abstract available.

30.

The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.

Okamura Y, Mishima S, Kashiwakura JI, Sasaki-Sakamoto T, Toyoshima S, Kuroda K, Saito S, Tokuhashi Y, Okayama Y.

Allergol Int. 2017 Sep;66S:S9-S20. doi: 10.1016/j.alit.2017.03.002. Epub 2017 Mar 31.

31.

CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.

Ueshima C, Kataoka TR, Takei Y, Hirata M, Sugimoto A, Hirokawa M, Okayama Y, Blumberg RS, Haga H.

Cancer Med. 2017 Apr;6(4):845-856. doi: 10.1002/cam4.1050. Epub 2017 Mar 23.

32.

Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis.

Kan J, Mishima S, Kashiwakura J, Sasaki-Sakamoto T, Seki M, Saito S, Ra C, Tokuhashi Y, Okayama Y.

Allergol Int. 2016 Sep;65 Suppl:S11-6. doi: 10.1016/j.alit.2016.04.007. Epub 2016 May 18.

33.

N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan.

Kouno Y, Anraku M, Yamasaki K, Okayama Y, Iohara D, Nakamura H, Maruyama T, Hirayama F, Kragh-Hansen U, Otagiri M.

Biochem Biophys Rep. 2016 Apr 26;6:266-274. doi: 10.1016/j.bbrep.2016.04.011. eCollection 2016 Jul.

34.

In utero-exposed di(n-butyl) phthalate induce dose dependent, age-related changes of morphology and testosterone-biosynthesis enzymes/associated proteins of Leydig cell mitochondria in rats.

Motohashi M, Wempe MF, Mutou T, Okayama Y, Kansaku N, Takahashi H, Ikegami M, Asari M, Wakui S.

J Toxicol Sci. 2016 Apr;41(2):195-206. doi: 10.2131/jts.41.195.

35.

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study.

Kaneko S, Ikeda K, Matsuzaki Y, Furuse J, Minami H, Okayama Y, Sunaya T, Ito Y, Inuyama L, Okita K.

J Gastroenterol. 2016 Oct;51(10):1011-21. doi: 10.1007/s00535-016-1173-5. Epub 2016 Mar 1.

36.

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M.

World Allergy Organ J. 2016 Feb 11;9:7. doi: 10.1186/s40413-016-0094-3. eCollection 2016. Review.

37.

[Fall risk factors and sex differences among community-dwelling elderly individuals in Japan. A Kameoka study].

Masumoto T, Yamada Y, Yamada M, Nakaya T, Miyake M, Watanabe Y, Yoshida T, Yokoyama K, Yamagata E, Date H, Nanri H, Komatsu M, Yoshinaka Y, Fujiwara Y, Okayama Y, Kimura M.

Nihon Koshu Eisei Zasshi. 2015;62(8):390-401. doi: 10.11236/jph.62.8_390. Japanese.

38.

MIP-1α level in nasopharyngeal aspirates at the first wheezing episode predicts recurrent wheezing.

Sugai K, Kimura H, Miyaji Y, Tsukagoshi H, Yoshizumi M, Sasaki-Sakamoto T, Matsunaga S, Yamada Y, Kashiwakura J, Noda M, Ikeda M, Kozawa K, Ryo A, Yoshihara S, Ogata H, Okayama Y.

J Allergy Clin Immunol. 2016 Mar;137(3):774-81. doi: 10.1016/j.jaci.2015.08.032. Epub 2015 Oct 19.

PMID:
26494023
39.

Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.

Nunomura S, Okayama Y, Matsumoto K, Hashimoto N, Endo-Umeda K, Terui T, Makishima M, Ra C.

Allergol Int. 2015 Sep;64 Suppl:S11-7. doi: 10.1016/j.alit.2015.03.001. Epub 2015 Mar 31.

40.

Japanese family with congenital factor VII deficiency.

Sakakibara K, Okayama Y, Fukushima K, Kaji S, Muraoka M, Arao Y, Shimada A.

Pediatr Int. 2015 Oct;57(5):1023-4. doi: 10.1111/ped.12696. Epub 2015 Aug 26.

PMID:
26310716
41.

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

Akaza H, Oya M, Iijima M, Hyodo I, Gemma A, Itoh H, Adachi M, Okayama Y, Sunaya T, Inuyama L.

Jpn J Clin Oncol. 2015 Oct;45(10):953-62. doi: 10.1093/jjco/hyv099. Epub 2015 Jul 22.

42.

NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosa.

Ueshima C, Kataoka TR, Hirata M, Koyanagi I, Honda T, Tsuruyama T, Okayama Y, Seiyama A, Haga H.

Exp Dermatol. 2015 Sep;24(9):675-9. doi: 10.1111/exd.12741. Epub 2015 May 26.

PMID:
25940096
43.

Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 3: role of the length of alditol side chain.

Tsutsui N, Tanabe G, Morita N, Okayama Y, Kita A, Sugiura R, Muraoka O.

Bioorg Med Chem. 2015 Jul 1;23(13):3761-73. doi: 10.1016/j.bmc.2015.03.079. Epub 2015 Apr 9.

PMID:
25910586
44.

[Target molecules for the treatment of allergic diseases].

Okayama Y.

Arerugi. 2015 Feb;64(1):9-13. Japanese. No abstract available.

PMID:
25779057
45.

The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.

Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H.

Cancer Immunol Res. 2015 Aug;3(8):871-80. doi: 10.1158/2326-6066.CIR-14-0199. Epub 2015 Mar 3.

46.

[Two cases of intrapelvic recurrence after radical resection of rectal cancer, treated with carbon ion radiotherapy].

Satake M, Yoshimatsu K, Yokomizo H, Yano Y, Nakayama M, Okayama Y, Matsumoto A, Fujimoto T, Usui T, Yamaguchi K, Shimakawa T, Shiozawa S, Katsube T, Naritaka Y, Yamada S.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1707-9. Japanese.

PMID:
25731303
47.

Enantioselective synthesis of macrocyclic heterobiaryl derivatives of molecular asymmetry by molybdenum-catalyzed asymmetric ring-closing metathesis.

Okayama Y, Tsuji S, Toyomori Y, Mori A, Arae S, Wu WY, Takahashi T, Ogasawara M.

Angew Chem Int Ed Engl. 2015 Apr 13;54(16):4927-31. doi: 10.1002/anie.201500459. Epub 2015 Feb 23.

PMID:
25706779
48.

Differentiation ability of multipotent hematopoietic stem/progenitor cells detected by a porcine specific anti-CD117 monoclonal antibody.

Ohshima S, Mori S, Shigenari A, Miyamoto A, Takasu M, Imaeda N, Nunomura S, Okayama Y, Tanaka M, Kitagawa H, Kulski JK, Inoko H, Ando A, Kametani Y.

Biosci Trends. 2014 Dec;8(6):308-15. doi: 10.5582/bst.2014.01084.

49.

Treatment of murine mast cells with IgEκ and protein L enhances apoptotic cell death induced by IL-3 withdrawal.

Nunomura S, Okayama Y, Terui T, Ra C.

Biochem Biophys Res Commun. 2015 Jan 9;456(2):700-5. doi: 10.1016/j.bbrc.2014.12.045. Epub 2014 Dec 15.

PMID:
25522877
50.

FcRγ promotes contact hypersensitivity to oxazolone without affecting the contact sensitisation process in B6 mice.

Nunomura S, Ohtsubo-Yoshioka M, Okayama Y, Terui T, Ra C.

Exp Dermatol. 2015 Mar;24(3):204-8. doi: 10.1111/exd.12622.

PMID:
25515858

Supplemental Content

Loading ...
Support Center